Most patients with rare diseases do not receive a molecular diagnosis and the aetiological
variants and causative genes for more than half such disorders remain to be discovered 1 . …

Characterizing the multifaceted contribution of genetic and epigenetic factors to disease
phenotypes is a major challenge in human genetics and medicine. We carried out high-…

The number and volume of cells in the blood affect a wide range of disorders including cancer
and cardiovascular, metabolic, infectious and immune conditions. We consider here the …

Purpose: Anticancer drugs gain access to solid tumors via the circulatory system and must
penetrate the tissue to kill cancer cells. Here, we study the distribution of doxorubicin in …

Measurements of erythrocytes within the blood are important clinical traits and can indicate
various hematological disorders. We report here genome-wide association studies (GWAS) …

In partnership with NHS England, Genomics England's ambitious plans to embed genomic
medicine into routine patient care are well underway. Clare Turnbull and colleagues discuss …

Anaemia is a chief determinant of global ill health, contributing to cognitive impairment,
growth retardation and impaired physical capacity. To understand further the genetic factors …

The Global Alliance for Genomics and Health (GA4GH) aims to accelerate biomedical
advances by enabling the responsible sharing of clinical and genomic data through both …

Introduction Blood production in humans culminates in the daily release of around 10 11
cells into the circulation, mainly platelets and red blood cells. All blood cells originate from a …

A fundamental problem in rare-disease diagnostics is the lack of consensus as to which
genes have sufficient evidence to attribute causation. To address this issue, we have created …